Clinical Trial Update: Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled [Phase 4]

View source ↗

Summary

Clinical trial update for hydromorphone used as perioperative analgesia in lung tumor ablation (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ablation
• Pulmonary Nodules

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Pulmonary Nodule, Ablation | Phase 4 | Status: UNKNOWN